LIFE Stock Overview
Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Lifecare AS Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr3.60 |
| 52 Week High | kr6.32 |
| 52 Week Low | kr1.42 |
| Beta | -0.053 |
| 1 Month Change | 12.15% |
| 3 Month Change | -10.67% |
| 1 Year Change | 86.05% |
| 3 Year Change | 5.88% |
| 5 Year Change | 63.64% |
| Change since IPO | 73.08% |
Recent News & Updates
Shareholder Returns
| LIFE | NO Medical Equipment | NO Market | |
|---|---|---|---|
| 7D | -10.0% | -2.5% | -1.7% |
| 1Y | 86.0% | -1.8% | 1.8% |
Return vs Industry: LIFE exceeded the Norwegian Medical Equipment industry which returned -1.8% over the past year.
Return vs Market: LIFE exceeded the Norwegian Market which returned 1.8% over the past year.
Price Volatility
| LIFE volatility | |
|---|---|
| LIFE Average Weekly Movement | 21.3% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in NO Market | 10.6% |
| 10% least volatile stocks in NO Market | 2.9% |
Stable Share Price: LIFE's share price has been volatile over the past 3 months.
Volatility Over Time: LIFE's weekly volatility has increased from 15% to 21% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 32 | Joacim Holter | www.lifecare.no |
Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes. It manufactures and develops nanostrain biosensors for measuring pressure and temperature in live tissue.
Lifecare AS Fundamentals Summary
| LIFE fundamental statistics | |
|---|---|
| Market cap | kr485.52m |
| Earnings (TTM) | -kr35.26m |
| Revenue (TTM) | kr13.09m |
37.1x
P/S Ratio-13.8x
P/E RatioIs LIFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LIFE income statement (TTM) | |
|---|---|
| Revenue | kr13.09m |
| Cost of Revenue | kr0 |
| Gross Profit | kr13.09m |
| Other Expenses | kr48.34m |
| Earnings | -kr35.26m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | -0.26 |
| Gross Margin | 100.00% |
| Net Profit Margin | -269.43% |
| Debt/Equity Ratio | 4.4% |
How did LIFE perform over the long term?
See historical performance and comparison